Recent advances in pharmacokinetic modeling

被引:38
作者
Ahmad, Alaa M. [1 ]
机构
[1] Vertex Pharmaceut Inc, Dept Clin Pharmacol, Cambridge, MA 02139 USA
关键词
pharmacokinetics; mechanistic models; compartmental modeling; population methodologies; ORAL CYCLOSPORINE PHARMACOKINETICS; MEDIATED DRUG DISPOSITION; POPULATION PHARMACOKINETICS; TRANSPLANT RECIPIENTS; PLASMA-CONCENTRATIONS; BAYESIAN-ESTIMATION; HUMAN LIVER; RAT-HEART; ABSORPTION; METABOLITES;
D O I
10.1002/bdd.540
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A major part of the science of pharmacokinetics is the modeling of the underlying processes that contribute to drug disposition. The purpose of pharmacokinetic models is to summarize the knowledge gained in preclinical and clinical studies at various stages in drug development and to rationally guide future studies with the use of adequately predictive models. This review highlights a variety of recent advances in mechanistic pharmacokinetic modeling. It is aimed at a broad audience, and hence, an attempt was made to maintain a balance between technical information and practical applications of pharmacokinetic modeling. It is hoped that drug researchers from all disciplines would be able to get a flavor of the function and capacity of pharmacokinetic modelers and their contribution to drug development. While this review is not intended to be a technical reference on modeling approaches, the roles of statistical applications and population methodologies are discussed where appropriate. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 51 条
[21]   Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers [J].
Lötsch, J ;
Skarke, C ;
Schmidt, H ;
Liefhold, J ;
Geisslinger, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) :151-162
[22]   Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty [J].
Mager, DE ;
Mascelli, MA ;
Kleiman, NS ;
Fitzgerald, DJ ;
Abernethy, DR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :969-976
[23]   Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-β1a monkeys [J].
Mager, DE ;
Neuteboom, B ;
Efthymiopoulos, C ;
Munafo, A ;
Jusko, WJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (01) :262-270
[24]   General pharmacokinetic model for drugs exhibiting target-mediated drug disposition [J].
Mager, DE ;
Jusko, WJ .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2001, 28 (06) :507-532
[25]   Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue [J].
Minotti, G ;
Parlani, M ;
Salvatorelli, E ;
Menna, P ;
Cipollone, A ;
Animati, F ;
Maggi, CA ;
Manzini, S .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (06) :1271-1278
[26]   Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0-12 monitoring in cardiac transplant recipients over the first year post-transplantation [J].
Monchaud, C ;
Rousseau, A ;
Leger, F ;
David, OJ ;
Debord, J ;
Dantoine, T ;
Marquet, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (12) :813-820
[27]   NONLINEAR RENAL AND BILIARY CLEARANCES OF ANTIVIRAL POLYOXOMETALATES IN RATS [J].
NI, L ;
BOUDINOT, FD .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1995, 20 (03) :209-217
[28]   Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers [J].
Ramakrishnan, R ;
Cheung, WK ;
Wacholtz, MC ;
Minton, N ;
Jusko, WJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (09) :991-1002
[29]   Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells [J].
Ranta, VP ;
Laavola, M ;
Toropainen, E ;
Vellonen, KS ;
Talvitie, A ;
Urtti, A .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1409-1416
[30]   Population pharmacokinetic modeling of oral cyclosporin using NONMEM -: Comparison of absorption pharmacokinetic models and design of a Bayesion estimator [J].
Rousseau, A ;
Léger, F ;
Le Meur, Y ;
Saint-Marcoux, F ;
Paintaud, G ;
Buchler, M ;
Marquet, P .
THERAPEUTIC DRUG MONITORING, 2004, 26 (01) :23-30